CLINICAL_TRIALS
trial_result
· 2013-06-11
Clinical Trial Update: Sorafenib Gastric Cancer Asian Phase I Study [Phase 1]
Summary
Phase I study of sorafenib in gastric cancer conducted in Asia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Gastric Cancer | Phase 1 | Status: COMPLETED